Related News

Nonselective Beta-Blocker Use Ups Survival in Ovarian Cancers

Aug 24, 2015

Longer median overall survival for patients receiving any beta-blocker versus nonusers

Earlier Ovary Removal Provides Greatest BRCA-Associated Benefit

Feb 26, 2014

In particular, women with BRCA1 mutation should have surgery by age 35, researchers say

ASCO: Pazopanib Ups Survival in Advanced Ovarian Cancer

Jun 4, 2013

Maintenance therapy linked to longer progression-free survival after surgery for advanced disease